Drug recall · December 22, 2021
Telmisartan and Hydrochlorothiazide Tablets recall
Why: Superpotent; Hydrochlorothiazide
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Telmisartan and Hydrochlorothiazide Tablets, USP, 40 mg/12.5 mg, 30 count bottles, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. Manufactured for: Torrent Pharma Inc., Basking Ridge, NJ 07920. NDC: 13668-159-30
- Lots / codes
Batch: BZ74G001 Exp. 12/2021.
- Quantity
- 27,312 Bottles
- Company
- Torrent Pharma Inc., Basking Ridge, NJ
- Distribution
- Nationwide USA
- Initiated
- December 1, 2021 · Voluntary: Firm initiated
- Classified
- December 16, 2021
- Reported
- December 22, 2021
- Ended
- May 12, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.